Search Results 21-30 of 21865 for Adenocarcinoma

  1. Institutional Analysis of Non-metastatic Pancreatic Adenocarcinoma Outcomes from 2011-2016 - Mayo Clinic

    Institutional Analysis of Non-metastatic Pancreatic Adenocarcinoma Outcomes from 2011-2016 · Overview · Participation eligibility · Participating Mayo Clinic ...

  2. Use of machine learning models to predict Barrett esophagus and esophageal adenocarcinoma risk - Mayo Clinic

    ... adenocarcinoma (EAC) ... Over the past 40 years, the incidence of esophageal adenocarcinoma (EAC) in the Western hemisphere has increased by approximately sixfold.

  3. 68GaFAPI-46 PET/CT for Pancreatic Ductal Adenocarcinoma - Mayo Clinic

    The purpose of this study is to examine the utility of 68GaFAPI-46 PET/CT imaging in adult patients with biopsy-proven Pancreatic Ductal Adenocarcinoma (PDA) ...

  4. Rectal cancer - Symptoms and causes - Mayo Clinic

    The majority of rectal cancers are adenocarcinomas. Adenocarcinoma is cancer that starts in gland cells, also called glandular cells. Gland cells are found ...

  5. Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma - Mayo Clinic

    This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...

  6. Ampullary cancer - Symptoms and causes - Mayo Clinic

    Ampullary adenocarcinoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1511. Accessed Aug. 29 ...

  7. Carcinoma of unknown primary - Symptoms and causes - Mayo Clinic

    In this type of cancer, healthcare professionals aren't sure where the cancer began. Treatments include chemotherapy, immunotherapy and targeted therapy.

  8. Assessing the risk of tumoremia after endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma - Mayo Clinic

    Most patients who undergo resection for pancreatic adenocarcinoma (PDAC) develop local recurrence, distant metastasis or both, but it is unclear whether ...

  9. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    Pancreatic ductal adenocarcinoma is one of the most aggressive types of cancer. In the absence of early detection methods and effective treatment, ...

  10. Noninvasive radiologic biomarkers to individualize lung cancer therapy - Mayo Clinic

    Invasive adenocarcinoma. Independent clustering of the CANARY glyphs stratifies these lesions into three distinct prognostic categories: good, intermediate and ...